NM_021098.3:c.2704C>T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2

The NM_021098.3(CACNA1H):​c.2704C>T​(p.Arg902Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000257 in 1,593,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R902Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

14
3
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.45

Publications

8 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.907
BS2
High AC in GnomAdExome4 at 39 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.2665C>T p.Arg889Trp missense_variant Exon 12 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.2665C>T p.Arg889Trp missense_variant Exon 12 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.2704C>T p.Arg902Trp missense_variant Exon 12 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*617C>T non_coding_transcript_exon_variant Exon 12 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*2151C>T non_coding_transcript_exon_variant Exon 11 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.2704C>T non_coding_transcript_exon_variant Exon 12 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*617C>T 3_prime_UTR_variant Exon 12 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*2151C>T 3_prime_UTR_variant Exon 11 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152254
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000275
AC:
6
AN:
218506
AF XY:
0.0000254
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000409
Gnomad OTH exome
AF:
0.000181
GnomAD4 exome
AF:
0.0000271
AC:
39
AN:
1441574
Hom.:
0
Cov.:
31
AF XY:
0.0000280
AC XY:
20
AN XY:
715016
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33012
American (AMR)
AF:
0.00
AC:
0
AN:
42432
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25634
East Asian (EAS)
AF:
0.0000258
AC:
1
AN:
38806
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82442
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51098
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5282
European-Non Finnish (NFE)
AF:
0.0000335
AC:
37
AN:
1103208
Other (OTH)
AF:
0.00
AC:
0
AN:
59660
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152254
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41464
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000834
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6 Uncertain:1
Sep 11, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Nov 22, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 902 of the CACNA1H protein (p.Arg902Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with autism spectrum disorder (PMID: 16754686). ClinVar contains an entry for this variant (Variation ID: 529571). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1H protein function. Experimental studies have shown that this missense change affects CACNA1H function (PMID: 16754686). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.31
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.92
D;.;.;.
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Benign
0.70
D
LIST_S2
Pathogenic
0.98
D;D;D;.
M_CAP
Pathogenic
0.74
D
MetaRNN
Pathogenic
0.91
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.7
H;.;H;H
PhyloP100
2.5
PrimateAI
Pathogenic
0.87
D
PROVEAN
Pathogenic
-5.8
D;.;D;D
REVEL
Pathogenic
0.79
Sift
Pathogenic
0.0
D;.;D;D
Sift4G
Pathogenic
0.0
D;.;D;D
Polyphen
1.0
D;.;D;D
Vest4
0.82
MutPred
0.66
Gain of MoRF binding (P = 0.1059);.;Gain of MoRF binding (P = 0.1059);Gain of MoRF binding (P = 0.1059);
MVP
0.97
ClinPred
0.99
D
GERP RS
1.9
Varity_R
0.81
gMVP
0.91
Mutation Taster
=22/78
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779011503; hg19: chr16-1256204; API